Stock·NYSE·Industrials
Builders FirstSource Inc. (BLDR)
- Market cap
- $6.05B
- P/E
- 61.18
- Dividend yield
- None
- Street target
- $68.00median of 24 analysts
- 52-week range
- $49.67 $131.50
BLDR stock forecast today
Where BLDR stands today, and what CleaRank Financial AI makes of it.
BLDR at a glance
Builders FirstSource Inc. (BLDR): Sell, 32/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($60.07 and $81.50).
- Insiders Insiders sold $572K and bought $60.7M over the last 18 months.
- Valuation P/E of 61.2 against 34.0 for the Industrials sector: a premium to peers (+80%).
Figures as of October 26, 2026.
CleaRank Financial AI
CleaRank rates Builders FirstSource Inc. (BLDR) Sell, with a model score of 32/100.
The analysts' outlook lifts the score most: the median target is 21.0% above the price. The trend holds it back most: the price is 31.03% below its 200-day average and 6.42% below its 50-day average, and the 50-day average is 26.30% below the 200-day. The 50-day average stands at $60.07 and the 200-day at $81.50. Over the past year the price fell 54.69%.
Only on CleaRank
Figures we compute ourselves from BLDR's own price, earnings and insider-filing history. Tap one to see it in context.
BLDR stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $56.21 is 6.4% below the 50-day simple moving average of $60.07.Price above its 200-day average ›
The price is 31.0% below the 200-day simple moving average of $81.50.50-day average above the 200-day ›
The 50-day average ($60.07) is 26.3% below the 200-day average ($81.50), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 8% of its 52-week range, between $49.67 and $131.50.
BLDR share price
Pick a period: each tab shows how far BLDR has moved over it, to the last close.
Today's trading
Where BLDR sits inside today's range and its 52-week range.
BLDR fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/3P/E below the sector median ›
The trailing P/E of 61.18 is 80.0% above the Industrials median of 34.0.P/S below the sector median ›
The price-to-sales ratio of 0.42 is 89.5% below the sector median of 4.0.Profitable over the last 12 months ›
Net income over the last 12 months was $102.6M on revenue of $14.4B, a net margin of 0.7%.
Key statistics
The headline figures for BLDR.
As of October 26, 2026, BLDR trades at $56.21, with a market value of $6.05B and a P/E ratio of 61.18.
What the numbers say
CleaRank Financial AI's reading of BLDR's valuation, growth and risks.
At 61.18 times trailing earnings, Builders FirstSource Inc. (BLDR) trades 80.0% above the Industrials median P/E of 34.0, which the peer comparison on this page labels a premium to peers. Measured on sales, the price-to-sales ratio of 0.42 is 89.5% below the sector median of 4.0. For scale, the company has a market capitalisation of $6.0B and trailing earnings of $0.92 per share.
Growth is the weak spot against the sector: in the latest quarter, year on year, revenue fell 8.80%, while the sector median rose 11.7%. BLDR keeps a net margin of 0.71%, an operating margin of 3.33% and a return on equity of 2.51%, which sits below the sector median of 17.8%. Its debt-to-equity ratio is 1.31.
BLDR's daily returns have a 30-day standard deviation of 2.63%, and its beta against the S&P 500 is 1.45. A P/E of 61.18 sits 80.0% above the sector median, which places BLDR at a premium to peers, so any shortfall in results could be judged harshly. The trend also weighs on holders until the price climbs back above its moving averages. The price is 57.25% below the 52-week high of $131.50.
BLDR against the Industrials sector
How BLDR compares with the median Industrials stock CleaRank tracks.
Price to earnings vs sector: BLDR trades at a significant premium to sector peers (+80%), suggesting market expectations for superior growth or market position.
Return vs XLI: Since May 14, 2025, BLDR has lost 53.0% against a gain of 18.8% for XLI.
Performance against XLI
BLDR and the Industrials sector fund over the same days.
Revenue and earnings
How much BLDR sells, and how much of it becomes profit.
Revenue growth: Revenue fell 7.4% in FY2025 to $15.2B, from $16.4B a year earlier.
Profit margin: The net margin was 2.9% in FY2025, down from 6.6% the year before.
Profitable: BLDR earned $435M in FY2025.
BLDR AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 49.3, in neutral territory.RSI above 50 ›
An RSI of 49.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of BLDR
The score, the reasoning behind it, and what could move the price next.
BLDR is trending down. The stock is 6.42% below its 50-day average of $60.07 and 31.03% below its 200-day average of $81.50, with the price at $56.21. It sits close to the floor of its 52-week range, 13.17% above the low of $49.67, and 57.25% below the high of $131.50. Both averages point the same way, since the 50-day is 26.30% below the 200-day.
The price is down over each of these periods: 5.00% over the past month, 22.70% over the past three months and 54.69% over the past year. The 14-day RSI of 49.3 is in the neutral zone, and the MACD line is negative.
Analyst downgrade ›
William Blair downgraded it to Market Perform from Outperform on October 22, 2026.
Source: Analyst action, William Blair, October 22, 2026Analyst downgrade ›
RBC Capital downgraded it to Sector Perform from Outperform on October 7, 2026.
Source: Analyst action, RBC Capital, October 7, 2026
- Keep an eye on the two levels closest to the price: the 50-day SMA at $60.07, just above it, and the 20-day EMA at $55.56, just below.
- The 14-day RSI is 49.3, which is in the neutral zone, and the MACD line is negative. Readings above 70 or below 30 would signal stretched momentum.
The trend is down because BLDR sits beneath both its 50-day ($60.07) and 200-day ($81.50) averages. A move back above the 50-day would be the first sign of repair. For now, the nearest level above the price is that same 50-day SMA at $60.07.
The 20-day EMA, at $55.56, is the nearest level beneath the price and the next marker to watch.
Technical indicators
Momentum and trend for BLDR, from its daily closes.
As of October 26, 2026, with BLDR at $56.21, its 14-day RSI is 49.3 (neutral territory), its 50-day simple moving average is $60.07 and its 200-day is $81.50.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What BLDR moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, BLDR's 1-year correlation of daily returns is +0.41 with S&P 500 (SPY), +0.31 with Nasdaq 100 (QQQ), +0.10 with Bitcoin (BTC) and +0.11 with gold (XAU).
BLDR price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
9 of 24 analysts rate it a buy or strong buy, 13 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $68.00 is 21.0% above the price.More buy ratings than three months ago ›
9 of 24 rate it a buy now, against 11 of 22 three months ago.
BLDR Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 22, 2026 | William Blair | Downgrade | Market Perform |
| Oct 16, 2026 | Oppenheimer | Maintains | Outperform |
| Oct 16, 2026 | Wells Fargo | Maintains | Equal-Weight |
| Oct 8, 2026 | Truist Securities | Maintains | Buy |
| Oct 7, 2026 | RBC Capital | Downgrade | Sector Perform |
| Oct 1, 2026 | StoneX | Maintains | Buy |
As of October 26, 2026, 24 Wall Street analysts cover BLDR: 9 rate it a buy or strong buy, 13 a hold and 2 a sell or strong sell. Their 12-month price targets range from $50.00 to $91.00. The median BLDR price target is $68.00, 21.0% above the price of $56.21.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
BLDR trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
BLDR trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Short entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from BLDR's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much BLDR tends to move, against the market and on its own.
BLDR price history and drawdowns
BLDR's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.63% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 76.1%, from March 2024 to October 2026; the price is still 73.4% below that peak.Most 1-year holds ended higher ›
65% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $57,770, against $42,015 in the S&P 500 (SPY).
BLDR Drawdowns & Recovery
As of October 26, 2026, BLDR's worst peak-to-trough fall over the last 10 years with dividends reinvested was -76.1% (March 2024 to October 2026); it is still 73.4% below that peak, and 65% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into BLDR in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: BLDR beat the S&P 500 over this period: $57,770 against $42,015.
A $10,000 investment in BLDR in October 2016 would be worth about $57,770 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to BLDR, and which have not.
Strongest month, November: an average of +11.81%, up in 8 of 10 years.
Weakest month, March: an average of -5.11%, up in 5 of 10 years.
This month, October: has averaged -2.34%, up in 3 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, BLDR's strongest calendar month has been November (average +11.81%, up in 8 of 10 years) and its weakest March (average -5.11%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
BLDR stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in BLDR, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in BLDR today could grow to about $14,697 by 2030 in the base case, with a 90th-percentile outcome near $50,617 and a 10th-percentile outcome around $4,268. Projections are statistical simulations, not guarantees.
BLDR Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $82.61 for BLDR by 2030 in the base case, from $56.21 today (1.5x over 4 years). The 10th-percentile path ends near $23.99. These are outcomes of a Monte Carlo simulation run on BLDR's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $33.35 | $61.89 | $115 | |
| 2028 | $28.42 | $68.15 | $163 | |
| 2029 | $25.71 | $75.03 | $219 | |
| 2030 | $23.99 | $82.61 | $285 |
Method: a lognormal simulation of BLDR's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. BLDR is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
BLDR insider trading
What the people running the company have bought and sold.
BLDR insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider buying: Insiders bought $60.7M on the open market and sold $572K.
As of October 26, 2026, BLDR insiders reported 2 open-market sales worth $572K and 4 open-market purchases worth $60.7M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 16, 2026 | Michael Hiller
Officer
|
Grant | 12.8K | - |
| Sep 10, 2026 | Cory Jacobs Boydston
Director
|
Grant | 470 | - |
| Sep 10, 2026 | Dirkson R Charles
Director
|
Grant | 470 | - |
| Sep 10, 2026 | Cleveland A Christophe
Director
|
Grant | 564 | - |
| Sep 10, 2026 | William B Hayes
Director
|
Grant | 583 | - |
| Sep 10, 2026 | Paul S Levy
Director
|
Grant | 1.2K | - |
| Sep 10, 2026 | James S O'Leary
Director
|
Grant | 564 | - |
| Sep 10, 2026 | Maria Renz
Director
|
Grant | 489 | - |
| Sep 10, 2026 | Craig Arthur Steinke
Director
|
Grant | 564 | - |
| Jul 17, 2026 | Brien Matthew Coley O
Officer
|
Grant | 7.4K | - |
| Jul 17, 2026 | Todd Vance
Officer
|
Grant | 3.4K | - |
| Jul 17, 2026 | Paul Vaughn
Officer
|
Grant | 3.4K | - |
| Jun 5, 2026 | Stephen J Herron
Chief Operating Officer
|
Grant | 850 | - |
| Jun 4, 2026 | Michael Hiller
Chief Operating Officer
|
Grant | 900 | - |
| Jun 1, 2026 | Mark Adam Alexander
Director
|
Grant | 409 | $31.2K |
| Jun 1, 2026 | Cory Jacobs Boydston
Director
|
Grant | 409 | $31.2K |
| Jun 1, 2026 | Dirkson R Charles
Director
|
Grant | 409 | $31.2K |
| Jun 1, 2026 | Cleveland A Christophe
Director
|
Grant | 491 | $37.4K |
| Jun 1, 2026 | William B Hayes
Director
|
Grant | 508 | $38.7K |
| Jun 1, 2026 | Paul S Levy
Director
|
Grant | 1.0K | $80.0K |
| Jun 1, 2026 | James S O'Leary
Director
|
Grant | 491 | $37.4K |
| Jun 1, 2026 | Maria Renz
Director
|
Grant | 426 | $32.5K |
| Jun 1, 2026 | Craig Arthur Steinke
Director
|
Grant | 491 | $37.4K |
| May 14, 2026 | Cheryl Ainoa
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Mark Adam Alexander
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Cory Jacobs Boydston
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Dirkson R Charles
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Cleveland A Christophe
Director
|
Grant | 2.6K | - |
| May 14, 2026 | William B Hayes
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Paul S Levy
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Brett N Milgrim
Director
|
Grant | 2.6K | - |
| May 14, 2026 | James S O'Leary
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Maria Renz
Director
|
Grant | 2.6K | - |
| May 14, 2026 | David E. Rush
Director
|
Grant | 2.6K | - |
| May 14, 2026 | Craig Arthur Steinke
Director
|
Grant | 2.6K | - |
| May 8, 2026 | David E. Rush
Director
|
Sell | 5.0K | $390.9K |
| Mar 13, 2026 | Jonathan P Cope
Officer
|
Grant | 5.7K | - |
| Mar 13, 2026 | Stephen J Herron
Chief Operating Officer
|
Grant | 22.0K | - |
| Mar 13, 2026 | Michael Hiller
Officer
|
Grant | 16.9K | - |
| Mar 13, 2026 | Peter M Jackson
Chief Executive Officer
|
Grant | 51.0K | - |
| Mar 13, 2026 | Paul S Levy
Director
|
Buy | 50.0K | $4.4M |
| Mar 13, 2026 | Gayatri Narayan
Officer
|
Grant | 9.4K | - |
| Mar 13, 2026 | Scott L. Robins
Officer
|
Grant | 15.1K | - |
| Mar 13, 2026 | Matthew Trester
Officer
|
Grant | 2.1K | - |
| Mar 13, 2026 | Todd Vance
Officer
|
Grant | 9.9K | - |
| Mar 13, 2026 | Paul Vaughn
Officer
|
Grant | 9.9K | - |
| Feb 27, 2026 | Mark Adam Alexander
Director
|
Grant | 299 | $31.2K |
| Feb 27, 2026 | Cory Jacobs Boydston
Director
|
Grant | 299 | $31.2K |
| Feb 27, 2026 | Dirkson R Charles
Director
|
Grant | 299 | $31.2K |
| Feb 27, 2026 | Cleveland A Christophe
Director
|
Grant | 359 | $37.4K |
| Feb 27, 2026 | William B Hayes
Director
|
Grant | 371 | $38.7K |
| Feb 27, 2026 | Paul S Levy
Director
|
Grant | 767 | $80.0K |
| Feb 27, 2026 | James S O'Leary
Director
|
Grant | 359 | $37.4K |
| Feb 27, 2026 | Maria Renz
Director
|
Grant | 311 | $32.4K |
| Feb 27, 2026 | Craig Arthur Steinke
Director
|
Grant | 359 | $37.4K |
| Dec 11, 2025 | Pete Beckmann
Chief Financial Officer
|
Grant | 2.0K | - |
| Dec 4, 2025 | David E. Rush
Director
|
Grant | 1.0K | - |
| Dec 1, 2025 | Mark Adam Alexander
Director
|
Grant | 278 | $31.2K |
| Dec 1, 2025 | Cory Jacobs Boydston
Director
|
Grant | 278 | $31.2K |
| Dec 1, 2025 | Dirkson R Charles
Director
|
Grant | 278 | $31.2K |
| Dec 1, 2025 | William B Hayes
Director
|
Grant | 345 | $38.7K |
| Dec 1, 2025 | Paul S Levy
Director
|
Grant | 712 | $79.9K |
| Dec 1, 2025 | James S O'Leary
Director
|
Grant | 334 | $37.5K |
| Dec 1, 2025 | Maria Renz
Director
|
Grant | 278 | $31.2K |
| Dec 1, 2025 | Craig Arthur Steinke
Director
|
Grant | 334 | $37.5K |
| Nov 5, 2025 | Peter M Jackson
Chief Executive Officer
|
Grant | 1.8K | - |
| Oct 1, 2025 | David E. Rush
Director
|
Grant | 24.3K | $2.9M |
| Aug 29, 2025 | Mark Adam Alexander
Director
|
Grant | 225 | $31.2K |
| Aug 29, 2025 | Cory Jacobs Boydston
Director
|
Grant | 225 | $31.2K |
| Aug 29, 2025 | Dirkson R Charles
Director
|
Grant | 225 | $31.2K |
| Aug 29, 2025 | William B Hayes
Director
|
Grant | 279 | $38.7K |
| Aug 29, 2025 | Paul S Levy
Director
|
Grant | 576 | $79.9K |
| Aug 29, 2025 | James S O'Leary
Director
|
Grant | 270 | $37.4K |
| Aug 29, 2025 | Maria Renz
Director
|
Grant | 225 | $31.2K |
| Aug 29, 2025 | Craig Arthur Steinke
Director
|
Grant | 270 | $37.4K |
| Aug 22, 2025 | Timothy D Johnson
General Counsel
|
Sell | 1.3K | $181.1K |
| Aug 22, 2025 | Timothy D Johnson
General Counsel
|
Grant | 370 | - |
| Jun 13, 2025 | Gayatri Narayan
Officer
|
Grant | 21.7K | - |
| Jun 10, 2025 | Todd Vance
Officer
|
Buy | 1.9K | $225.0K |
| May 30, 2025 | Mark Adam Alexander
Director
|
Grant | 290 | $31.2K |
| May 30, 2025 | Cory Jacobs Boydston
Director
|
Grant | 290 | $31.2K |
| May 30, 2025 | Dirkson R Charles
Director
|
Grant | 290 | $31.2K |
| May 30, 2025 | William B Hayes
Director
|
Grant | 359 | $38.7K |
| May 30, 2025 | Paul S Levy
Director
|
Grant | 742 | $79.9K |
| May 30, 2025 | James S O'Leary
Director
|
Grant | 379 | $40.8K |
| May 30, 2025 | Maria Renz
Director
|
Grant | 297 | $32.0K |
| May 30, 2025 | Craig Arthur Steinke
Director
|
Grant | 348 | $37.5K |
| May 27, 2025 | Cheryl Ainoa
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Mark Adam Alexander
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Cory Jacobs Boydston
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Dirkson R Charles
Director
|
Buy | 5.0K | $548.4K |
| May 27, 2025 | Dirkson R Charles
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Cleveland A Christophe
Director
|
Grant | 1.7K | - |
| May 27, 2025 | William B Hayes
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Paul S Levy
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Brett N Milgrim
Director
|
Grant | 1.7K | - |
| May 27, 2025 | James S O'Leary
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Maria Renz
Director
|
Grant | 1.7K | - |
| May 27, 2025 | David E. Rush
Director
|
Grant | 1.7K | - |
| May 27, 2025 | Craig Arthur Steinke
Director
|
Grant | 1.7K | - |
| May 13, 2025 | Stephen J Herron
Chief Operating Officer
|
Grant | 130 | - |
| May 9, 2025 | Paul S Levy
Director
|
Buy | 500.0K | $55.6M |
Source: TwelveData, from SEC Form 4 filings
BLDR stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.